Modulator

A compound and alkyl technology, applied in the field of regulating cannabinoid receptors, to achieve the effect of reducing lipophilicity and improving water solubility

Inactive Publication Date: 2008-02-06
UCL BUSINESS PLC
View PDF9 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] It is an object of the present invention to provide cannabinoid receptor modulators that alleviate and / or eliminate some of the disadvantages commonly associated with prior art modulators, such as undesired psychoactive side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Modulator
  • Modulator
  • Modulator

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0234] overview

[0235] Unless noted, all starting materials were either commercially available or reported in previous literature. Solvents and reagents were used without further purification, except tetrahydrofuran (THF), which was dried over sodium. The reaction was monitored by thin layer chromatography (TCL) on precoated silica gel plates (Kieselgel 60F254, Merck). Unless otherwise noted, use Still 36 Purification was carried out by flash chromatography using a column packed with silica gel (particle size 40-63 μM, Merck). Recorded on a Bruker AMX-300 spectrometer 1 H and 13 CNMR spectrum. Chemical shifts are reported in ppm. Coupling constants are in Hz. Mass spectra were recorded on a VG ZAB SE spectrometer (ESP, FAB) or a Micromass Quattro electrospray liquid crystal mass spectrometer (LCMS). Using CEM Focused Microwave TM The Synthesis System performs certain Suzuki coupling reactions.

[0236] synthesis

[0237] Compounds of formula I were synthesized by...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a compound of formula I or a pharmaceutically acceptable salt thereof. In formula (I), R 1 and R 2 Each independently is H or alkyl; Y is alkyl, CONR 3 R 4 、COOR 5 , SO 2 NR 16 R 17 , NHSO 2 R 18 or CN; X is aryl or heteroaryl, each of which may optionally be substituted by one or more substituents selected from (CH 2 ) m Z, where Z is halogen, OH, CN, alkyl, alkoxy, NO 2 、CF 3 、CONR 6 R 7 , CN, NR 8 R 9 、COOR 10 or NHCOR 11 , m is 0 to 3; R 3 to R 11 Each is independently H, alkyl or aryl, wherein the alkyl and aryl are optionally substituted by one or more substituents selected from halogen, OH, CN, alkyl, alkoxy , NO 2 、CF 3 、CONR 12 R 13 , CN, NH 2 、COOR 14 , NHCOR 15 and CN; R 12 to R 18 Each independently is H or alkyl, more preferably H or Me; n is 1 to 6; wherein the compound is not 3',5'-dimethyl-4-(1,1-dimethylheptyl)- 1,1'-biphenyl-2-phenol. Another aspect of the invention relates to the use of such compounds for the manufacture of a medicament for the treatment of muscular disorders, gastrointestinal disorders or for the control of spasticity or tremor.

Description

technical field [0001] The present invention relates to the ability to modulate cannabinoid receptors (cannabinoid receptors), especially peripheral CB 1 receptor compounds. Background technique [0002] There has recently been renewed interest in medical marijuana and the therapeutic use of synthetic cannabinoids, such as the active component of marijuana-Δ 9 - Tetrahydrocannabinol (THC) [1]. [0003] [0004] THC has therapeutic advantages in several major areas of medicine, including control of acute pain and especially chronic / neuropathic pain, nausea, loss of appetite, AIDS, glaucoma, asthma and multiple sclerosis [Baker, D. et al, Nature 2000, 404, 84-87; Baker, D. et al FASEB J. 2001, 15, 300-302; Schnelle, M. et al, Forsch. Komplement armed. 1999, 6 Suppl 3, 28-36]. [0005] Various cannabinoid ligands have been reported in the literature. Broadly speaking, cannabinoid ligands can be divided into three major categories including: (i) typical cannabinoids such ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C39/15C07C235/26C07C233/03C07D213/02A61K31/055A61K31/05A61K31/167A61K31/165A61P21/00C07C37/055C07C37/11C07C37/62C07C39/06C07C39/27C07C39/367C07C45/00C07C59/90C07C67/343C07C233/25C07C235/34C07D213/30
CPCC07C235/34C07C37/18C07C41/30C07C39/367C07C37/055C07C233/25C07C45/004C07C39/15C07C37/11C07C67/343C07C37/62C07C59/90C07D213/30A61P1/00A61P1/04A61P1/12A61P11/00A61P11/06A61P13/00A61P13/10A61P21/00A61P25/00A61P25/02A61P25/08A61P25/16A61P29/00A61P43/00C07C49/84C07C69/738C07C43/205C07C39/06C07C39/27C07C39/12
Inventor 戴维·塞尔伍德克利斯蒂娜·维辛廷戴维·贝克加雷斯·普赖斯奥山正弘
Owner UCL BUSINESS PLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products